Brown University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Brown University sits in the top decile of US sponsors by registered trial count (#141 of 15,742 sponsors by registered trial count).

231 total trials 34 currently recruiting 156 completed early-phase tilt top decile by trial count

Brown University: 231 sponsored US clinical trials, 34 recruiting.

Brown University sponsors 231 registered US clinical trials on ClinicalTrials.gov, 34 of them currently recruiting, and 156 completed. 6 of these trials are in Phase 3-4 (later-stage) and 89 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Alcohol Drinking, with 8 trials.

Top-decile sponsor footprint

Brown University ranks in the top decile of sponsors by registered trial count (#141 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 57/100

156 of 179 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (87.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

231 total, page 5 of 5

COMPLETED Phase 1

Integrated Treatment for Comorbid Depression and Obesity in Adolescents

NCT01128764

COMPLETED Phase 2

Biobehavioral Effects of Topiramate on Cannabis-Related Outcomes in Adolescents

NCT01110434

COMPLETED Phase 2

Naltrexone for At-Risk and Problem Drinking in Smoking Cessation Treatment

NCT00938886

COMPLETED NA

Concurrent Treatment for Depressed Parents and DepressedAdolescents

NCT00951821

COMPLETED Phase 2

Smoking Abstinence and Lapse Effects in Smokers With Schizophrenia and Controls

NCT01214005

TERMINATED Phase 1

A Study of Dasatinib With Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer (NSCLC)

NCT00787852

COMPLETED NA

Med Diet Prevention Metabolic Syndrome Men Undergoing Androgen Deprivation Therapy Prostate Cancer

NCT01083771

COMPLETED Phase 2

Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate Cancer

NCT00828308

COMPLETED NA

Varenicline and Motivational Advice for Smokers With Substance Use Disorders

NCT00756275

COMPLETED Phase 2

Lenalidomide for Advanced Hepatocellular Cancer:A Phase II Trial

NCT00717756

COMPLETED NA

Contingency Management for Smoking in Substance Abusers

NCT00807742

COMPLETED Phase 1

Family Check-Up for Adolescents and Siblings

NCT00925340

COMPLETED Phase 1

Matching Genotypes and Serotonergic Medications for Alcoholism

NCT01113164

COMPLETED Phase 1

Substance Use Prevention in Teen Psychiatric Patients

NCT01170013

TERMINATED Phase 2

Decitabine, Cytarabine, GCSF for Refractory AML/MDS

NCT00740181

TERMINATED Phase 2

Trial of Chemotherapy and Avastin as Treatment for Women With Breast Cancer at High Risk for Relapse

NCT00462865

COMPLETED Phase 2

Neoadjuvant Paclitaxel Poliglumex, Cisplatin and Radiation for Esophageal Cancer: A Phase II Trial (CTI#X64001)

NCT00522795

TERMINATED Phase 1

BrUOG-PA-209: Lapatinib and Gemcitabine for Metastatic Pancreaticobiliary Cancer

NCT00447122

COMPLETED NA

Group Therapy for Women Prisoners With Comorbid Substance Use and Depression

NCT00606996

COMPLETED Phase 1

A Trial of GW572016, Gemcitabine and Oxaliplatin for Metastatic Pancreaticobiliary Cancer Schema

NCT00439179

COMPLETED NA

Education and Counseling for Abstinence From Tobacco After Pregnancy

NCT00139529

COMPLETED Phase 2

Nicotine and Sensorimotor Replacement for Smoking in Smokers With Schizophrenia

NCT01213524

COMPLETED Phase 3

Treatment of Apathy in Alzheimer's Disease With Modafinil

NCT01172145

COMPLETED Phase 2

Cetuximab, Paclitaxel, Carboplatin & Radiation for Esoph, Gastroesoph & Gastric Cancer

NCT00439608

COMPLETED Phase 2

Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia

NCT00136760

COMPLETED Phase 2

Improving Smoking Cessation Outcomes in Heavy Drinkers - 1

NCT00107575

COMPLETED Phase 3

Motivational Interviewing for Alcohol-Positive Teens in the Emergency Room

NCT00246428

COMPLETED Phase 1

Brief Intervention for Families of Teens Treated in the Emergency Department for an Alcohol-Related Event

NCT00247221

COMPLETED NA

Motivational Interviews for Incarcerated Teens - 1

NCT00227916

COMPLETED NA

Nutrition Education for Low-Income Healthy Participants Who Eat an Unhealthy Diet

NCT00301691

COMPLETED Phase 4

Naltrexone, Craving, and Drinking

NCT00006203

← Previous Page 5 of 5

Phase Distribution

PhaseTrial count
Phase 1 32
Phase 2 57
Phase 3 4
Phase 4 2

What is open in the Brown University pipeline

34 recruiting of 231 indexed (15% open); 156 completed (68%).

Phase mix: 6 late (III/IV) vs 89 early (I/II) (early-phase heavy).

Top condition: Alcohol Drinking (8 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Brown University: open-pipeline peers nationwide

Peers matched on 231 registered trials and 15% open enrollment, not the therapeutic-area sidebar.

Brown University sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0200400600800 10%12%14%16%18%20% Total trials Recruiting share Brown UniversityUniversity Hospitals Cleveland Medical CenterHenry Ford Health SystemUniversity of IowaGeorgetown UniversityAmicus TherapeuticsLoma Linda UniversityUniversity of RochesterUnited States Naval Medical Center, San Diego
Brown University sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Brown University sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 231 trials (± recruiting share)

Sponsors near 15% open enrollment (± trial volume)

What to do with this Brown University page

231 registered trials is a research-attention snapshot, not an endorsement of Brown University or any single study.

  • 34 of Brown University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Alcohol Drinking is the condition Brown University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Alcohol Drinking trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Brown University pipeline card: 231 registered trials from official public datasets.Report a data error.